Diabetes mellitus and obesity: phenformin hydrochloride as a research tool. Concluding remarks.
D000138:Acidosis; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D003920:Diabetes Mellitus / Q000188:drug therapy; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005943:Gluconeogenesis / Q000187:drug effects; D005951:Glucose Tolerance Test; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology; D007328:Insulin / Q000097:blood; D007773:Lactates / Q000097:blood; D008055:Lipids / Q000097:blood; D008099:Liver / Q000378:metabolism; D009765:Obesity; D010088:Oxidoreductases / Q000037:antagonists & inhibitors; D010629:Phenformin / Q000494:pharmacology* / Q000627:therapeutic use; D010743:Phospholipids / Q000097:blood; D014280:Triglycerides / Q000097:blood
D005230:Fatty Acids, Nonesterified; D000960:Hypolipidemic Agents; D007328:Insulin; D007773:Lactates; D008055:Lipids; D010743:Phospholipids; D014280:Triglycerides; D010629:Phenformin; D010088:Oxidoreductases